Valium and Hypercoagulation - a phase IV clinical study of FDA data

Summary:

Hypercoagulation is reported as a side effect among people who take Valium (diazepam), especially for people who are female, 40-49 old, also take Coumadin, and have Breast cancer.

The phase IV clinical study analyzes which people have Hypercoagulation when taking Valium. It is created by eHealthMe based on reports of 45,658 people who have side effects when taking Valium from the FDA, and is updated regularly.

What is Valium?

Valium has active ingredients of diazepam. It is often used in stress and anxiety. eHealthMe is studying from 48,647 Valium users. Check the latest studies of Valium.

What is Hypercoagulation?

Hypercoagulation (increased tendency for clotting of the blood) is found to be associated with 380 drugs and 538 conditions by eHealthMe. Check the latest studies of Hypercoagulation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

45,658 people reported to have side effects when taking Valium.
Among them, 15 people (0.03%) have Hypercoagulation.

Among these 15 people:

What is the gender of people who have Hypercoagulation when taking Valium? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Hypercoagulation when taking Valium? *

What are other drugs people take besides Valium? *

What are other side effects people have besides Hypercoagulation? *

Back Pain: 8 people, 53.33%
Pulmonary Embolism (blockage of the main artery of the lung): 7 people, 46.67%
Dyspnea (difficult or laboured breathing): 7 people, 46.67%
Hypokalemia (low potassium): 7 people, 46.67%
Chest Pain: 7 people, 46.67%
Weakness: 6 people, 40.00%
Pain: 6 people, 40.00%
Neuropathy Peripheral (surface nerve damage): 6 people, 40.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 40.00%
Rashes (redness): 6 people, 40.00%

What are the existing conditions these people have? *

Breast Cancer: 4 people, 26.67%
Uterine Leiomyoma (uterine benign tumour derived from smooth muscle): 3 people, 20.00%
Sleep Disorder: 2 people, 13.33%
Bleeding Disorders: 2 people, 13.33%
Breakthrough Pain: 2 people, 13.33%
Depression: 2 people, 13.33%
High Blood Cholesterol: 2 people, 13.33%
High Blood Pressure: 2 people, 13.33%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 13.33%
Kidney Stones: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Valium and have Hypercoagulation?

- Check whether Hypercoagulation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Valium:

Valium (48,647 reports)

Browse all side effects of Valium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypercoagulation:

Hypercoagulation (380 drugs)

Browse all the conditions that are associated with Hypercoagulation:

Hypercoagulation (538 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diazepam (the active ingredients of Valium) and Valium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.